Original language | English (US) |
---|---|
Pages (from-to) | 4124-4133 |
Number of pages | 10 |
Journal | Cancer |
Volume | 125 |
Issue number | 23 |
DOIs |
|
State | Published - Dec 1 2019 |
Keywords
- geriatric assessment
- geriatric oncology
- patient advocates
- patient partners
- stakeholders
ASJC Scopus subject areas
- Oncology
- Cancer Research
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Cancer, Vol. 125, No. 23, 01.12.2019, p. 4124-4133.
Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - Engaging older patients with cancer and their caregivers as partners in cancer research
AU - Gilmore, Nikesha J.
AU - Canin, Beverly
AU - Whitehead, Mary
AU - Sedenquist, Margaret
AU - Griggs, Lorraine
AU - Finch, Lynn
AU - Grossman, Valerie
AU - Targia, Valerie
AU - Wells, Megan
AU - Kamen, Charles
AU - Flannery, Marie
AU - Magnuson, Allison
AU - Plumb, Sandy
AU - Obrecht, Spencer
AU - Lowenstein, Lisa M.
AU - Lopez, Gilberto
AU - Anderson, Jainy
AU - Berenberg, Jeffrey
AU - Vogel, Victor
AU - Bearden, James
AU - Dale, William
AU - Mohile, Supriya G.
N1 - Funding Information: Supported by a Patient‐Centered Outcomes Research Institute (PCORI) Program contract (contract 4634) and by grants from the National Cancer Institute of the National Institutes of Health (grants R21 AG059206‐01, UG1 CA189961, R01 CA177592, and K24 AG056589). All statements in this report, including its findings and conclusions, are solely those of the authors; do not necessarily represent the official views of the funding agencies; and do not necessarily represent the views of the Patient‐Centered Outcomes Research Institute (PCORI), its Board of Governors, or its Methodology Committee. Funding Information: Nikesha J. Gilmore, Megan Wells, Charles Kamen, Marie Flannery, Allison Magnuson, Sandy Plumb, Spencer Obrecht, Gilberto Lopez, Jainy Anderson, and Supriya G. Mohile were supported by a Patient-Centered Outcomes Research Institute (PCORI) Program contract (contract 4634) and by grants from the National Cancer Institute at the National Institutes of Health (grants R21 AG059206-01, UG1 CA189961, R01 CA177592, and K24 AG056589) (Principal Investigator: Supriya Mohile) for work performed as part of the current study. All statements in this report, including its findings and conclusions, are solely those of the authors, do not necessarily represent the official views of the funding agencies, and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors, or Methodology Committee. Marie Flannery has received grants from the National Cancer Institute of the National Institutes of Health (grants UG1CA189961 and NCI R25 CA102618) for work performed as part of the current study. Jeffrey Berenberg has received a National Cancer Institute (NCI) NCI Community Oncology Research Program grant for work performed as part of the current study. James Bearden has received an NCI Community Oncology Research Program grant for work performed as part of the current study. The other authors made no disclosures. Supported by a Patient-Centered Outcomes Research Institute (PCORI) Program contract (contract 4634) and by grants from the National Cancer Institute of the National Institutes of Health (grants R21 AG059206-01, UG1 CA189961, R01 CA177592, and K24 AG056589). Funding Information: Nikesha J. Gilmore, Megan Wells, Charles Kamen, Marie Flannery, Allison Magnuson, Sandy Plumb, Spencer Obrecht, Gilberto Lopez, Jainy Anderson, and Supriya G. Mohile were supported by a Patient‐Centered Outcomes Research Institute (PCORI) Program contract (contract 4634) and by grants from the National Cancer Institute at the National Institutes of Health (grants R21 AG059206‐01, UG1 CA189961, R01 CA177592, and K24 AG056589) (Principal Investigator: Supriya Mohile) for work performed as part of the current study. All statements in this report, including its findings and conclusions, are solely those of the authors, do not necessarily represent the official views of the funding agencies, and do not necessarily represent the views of the Patient‐Centered Outcomes Research Institute (PCORI), its Board of Governors, or Methodology Committee. Marie Flannery has received grants from the National Cancer Institute of the National Institutes of Health (grants UG1CA189961 and NCI R25 CA102618) for work performed as part of the current study. Jeffrey Berenberg has received a National Cancer Institute (NCI) NCI Community Oncology Research Program grant for work performed as part of the current study. James Bearden has received an NCI Community Oncology Research Program grant for work performed as part of the current study. The other authors made no disclosures. Funding Information: SCOREboard's participation in the COACH trial forever shaped the way the COACH research team views clinical research. Efforts now are made to view each research proposal through the eyes of the study's patient population, who are the individuals with the most to gain from the study's outcomes. At the onset of every new research idea, the following questions are asked: 1) how does this impact the patient population; 2) what are the patients' preferences; and 3) are the questions framed in such a way that the average patient can understand? As a direct result of the tremendous benefits experienced after engaging with SCOREboard, all new research concepts proposed by the research team contain detailed input from SCOREboard. SCOREboard currently is funded through a National Institute on Aging R21/R33 phased innovation grant to develop a national infrastructure for cancer and aging research (William Dale, MD, PhD, Arti Hurria, MD, and Supriya G. Mohile, MD, MS). The positive outcomes of engaging with SCOREboard throughout the COACH trial was evidenced by researchers in the University of Rochester's internal and external networks. SCOREboard's input is highly requested by researchers at the University of Rochester Medical Center, and SCOREboard has aided researchers from that institution in grant applications for 2 infrastructure funding mechanisms to advance research in the area of geriatric oncology (including the R21/R33 geriatric oncology infrastructure grant), 7 clinical trials focused on geriatric oncology, and 3 conferences to establish research priorities. Eight of these efforts received funding, and 3 are pending a funding decision.
PY - 2019/12/1
Y1 - 2019/12/1
KW - geriatric assessment
KW - geriatric oncology
KW - patient advocates
KW - patient partners
KW - stakeholders
UR - http://www.scopus.com/inward/record.url?scp=85070797031&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070797031&partnerID=8YFLogxK
U2 - 10.1002/cncr.32402
DO - 10.1002/cncr.32402
M3 - Comment/debate
C2 - 31420878
AN - SCOPUS:85070797031
SN - 0008-543X
VL - 125
SP - 4124
EP - 4133
JO - Cancer
JF - Cancer
IS - 23
ER -